114 results
Page 4 of 6
6-K
EX-1
1z388c9wjhm 6okp
26 Oct 20
Current report (foreign)
9:00am
6-K
EX-1
kha pdahu02cfw
13 Oct 20
Current report (foreign)
10:30am
6-K
EX-1
sjnp31
22 Sep 20
Current report (foreign)
10:08am
6-K
EX-99.1
p70mciwt2dphfxh1u273
8 Sep 20
RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARS-CoV-2
8:30am
6-K
EX-2
6zz 8grhkag3d29n0
13 Aug 20
Current report (foreign)
7:03am
6-K
EX-1
qelfu4tjxbzsao bb
27 Jul 20
Current report (foreign)
7:00am
6-K
EX-2
5w3 od3aaxk
27 May 20
Current report (foreign)
7:00am
6-K
EX-99.1
wf3ke2yg23
28 Apr 20
RedHill Biopharma Strengthens Coverage for Talicia® with Preferred Brand Position on Prime Therapeutics NetResults™ National Formulary
7:00am
6-K
EX-99.1
m9ujqk3e5ld1a5gyv
13 Mar 20
RedHill recently launched Talicia® in the U.S., calling on gastroenterologists, primary care physicians and other healthcare providers
7:00am
6-K
EX-99.1
06reiwrkttp98sfj2iwx
9 Mar 20
RedHill Biopharma Announces U.S. Commercial Launch of Talicia® for H. pylori Infection
7:04am
6-K
EX-99.1
x1km6duc23o 1la
27 Jan 20
RedHill Biopharma Launches H. pylori Disease State Awareness Field Campaign Ahead of Talicia® Launch
7:00am
6-K
EX-99.1
29gnov
4 Nov 19
RedHill Biopharma Announces FDA Approval of Talicia® for Treatment of H. pylori in Adults
6:05am
6-K
EX-99.1
rwhsuwmmkfk0wys
16 Oct 19
Current report (foreign)
8:00am
424B5
plb9tvxsiush8vp
23 Jul 19
Prospectus supplement for primary offering
8:31am
6-K
EX-2
ndsopae h6k5yd
23 Jul 19
Current report (foreign)
7:27am
6-K
EX-99.1
kaaws
3 Jul 19
Current report (foreign)
7:00am
6-K
EX-2
jbqjoyzg8j0jd9nt2g8v
7 May 19
Current report (foreign)
7:01am
6-K
EX-1
54u1f
7 May 19
Current report (foreign)
7:01am